The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe
Drug Testing and Analysis · 2025
DOI: 10.1002/dta.3841 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Testing and Analysis, 2025. Verfasst von Celine Vanhee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Service Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium. Hauptthemen laut MEDLINE: Nicotine, Tobacco Products. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
A new nicotine delivery system in the form of tobacco‐free nicotine pouches was introduced in Europe in 2019. These nicotine bags did not fall under the Tobacco Products Directive (TPD) II, which brought forward regulatory requirements for both cigarettes, related products, and e‐liquids. As these pouches did not fall under the scope of the TPD, it was up to the member states to decide which action to be taken if any. Some EU member states banned these nicotine pouches, while others put restrictions on the amount of nicotine, warning messages, and presentation and packaging of the product, and some member states did not take any action. Likely as a result of the ban or restrictions, soon after also, tobacco and nicotine‐free pouches became available in the European Union (EU). Early 2024, “NoNIC” pouches, claiming to be tobacco‐ and nicotine‐free, became available on the European market. These pouches are promoted online and clearly target a younger population with a youth‐appealing package design and enticing flavors. Upon analysis of different samples utilizing gas chromatography coupled to MS (GC–MS), liquid chromatography coupled to high‐resolution tandem mass spectrometry (HRAM LC–MS2), and nuclear magnetic resonance spectroscopy (NMR), it was demonstrated that these pouches were indeed devoid of nicotine but contained the synthetic nicotine homolog 6‐methyl nicotine (6‐MN) and this up to 20 mg per pouch. Nonetheless, a part of a likely unaware/misled young adult subpopulation has easy access to these products, containing a novel molecule for which limited to no clinical effects are known.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service Medicines and Health Products, Scientific Direction of Chemical and Physical Health Risks, Sciensano, Brussels, Belgium.
- Natural Products & Food Research and Analysis-Pharmaceutical Technology (NatuRAPT), Department of Pharmaceutical Sciences, University of Antwerp, Antwerp, Belgium.
ORCID-Profile: Celine Vanhee
Zitieren
APA
Vanhee, C., Dill, M., Canfyn, M., Tuenter, E., & Barhdadi, S. (2025). The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe. Drug Testing and Analysis. https://doi.org/10.1002/dta.3841
Vancouver
Vanhee C, Dill M, Canfyn M, Tuenter E, Barhdadi S. The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe. Drug Testing and Analysis. 2025. doi:10.1002/dta.3841
BibTeX
@article{Vanhee2025,
author = {Vanhee, Celine and Dill, Maarten and Canfyn, Michael and Tuenter, Emmy and Barhdadi, Sophia},
title = {The Emergence of a Novel Synthetic Nicotine Analog 6‐Methyl Nicotine (6‐MN) in Proclaimed Tobacco‐ and Nicotine‐Free Pouches Available in Europe},
journal = {Drug Testing and Analysis},
year = {2025},
doi = {10.1002/dta.3841}
}
EUVIMED